QUIE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
QUIE PHARMA
Largest movements
- Current investments +€81,032
new in 2025: €81,032
- Cash +€21,625
up €21,625 (+73.8%), from €29,294 to €50,920
mainly Net result for the year (+€137,242) and Depreciation (+€2,028)
- Receivables within one year +€16,452
up €16,452 (+7.4%), from €222,704 to €239,156
of which Other amounts receivable: +€44,568
- Tangible fixed assets +€5,835
up €5,835 (+102%), from €5,743 to €11,578
of which Land and buildings: +€3,984
- Reserves +€137,000
up €137,000 (+168%), from €81,700 to €218,700
of which Distributable reserves: +€137,000
- Other debts -€6,299
down €6,299 (-93.4%), from €6,746 to €447
- Trade debts -€6,192
down €6,192 (-68.8%), from €9,002 to €2,810
- Gross operating margin +€137,637
up €137,637 (+200%), from €68,972 to €206,609
- Taxes +€41,936
up €41,936 (+176%), from €23,870 to €65,806
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €258,596 | €383,563 | +€124,968 | +48.3% |
| Fixed assets | 21/28 | €5,743 | €11,578 | +€5,835 | +102% |
| Tangible fixed assets | 22/27 | €5,743 | €11,578 | +€5,835 | +102% |
| Land and buildings | 22 | €300 | €4,284 | +€3,984 | +1,328% |
| Plant, machinery and equipment | 23 | €1,686 | €3,928 | +€2,243 | +133% |
| Furniture and vehicles | 24 | €3,758 | €3,366 | -€392 | -10.4% |
| Current assets | 29/58 | €252,852 | €371,985 | +€119,133 | +47.1% |
| Amounts receivable within one year | 40/41 | €222,704 | €239,156 | +€16,452 | +7.4% |
| Trade receivables | 40 | €90,735 | €62,620 | -€28,116 | -31.0% |
| Other amounts receivable | 41 | €131,969 | €176,536 | +€44,568 | +33.8% |
| Current investments | 50/53 | - | €81,032 | +€81,032 | |
| Cash at bank and in hand | 54/58 | €29,294 | €50,920 | +€21,625 | +73.8% |
| Deferred charges and accrued income | 490/1 | €854 | €877 | +€23 | +2.7% |
| Total equity and liabilities | 10/49 | €258,596 | €383,563 | +€124,968 | +48.3% |
| Equity | 10/15 | €191,939 | €329,180 | +€137,242 | +71.5% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €81,700 | €218,700 | +€137,000 | +168% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €79,840 | €216,840 | +€137,000 | +172% |
| Profit (loss) carried forward | 14 | €104,039 | €104,280 | +€242 | +0.2% |
| Amounts payable | 17/49 | €66,657 | €54,383 | -€12,274 | -18.4% |
| Amounts payable within one year | 42/48 | €66,657 | €54,383 | -€12,274 | -18.4% |
| Trade debts | 44 | €9,002 | €2,810 | -€6,192 | -68.8% |
| Suppliers | 440/4 | €9,002 | €2,810 | -€6,192 | -68.8% |
| Taxes, remuneration and social security | 45 | €50,909 | €51,126 | +€217 | +0.4% |
| Taxes | 450/3 | €50,909 | €51,126 | +€217 | +0.4% |
| Other amounts payable | 47/48 | €6,746 | €447 | -€6,299 | -93.4% |
| Non-recurring operating income | 76A | - | €5,443 | +€5,443 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,618 | €2,028 | +€410 | +25.3% |
| Other operating charges | 640/8 | €573 | €400 | -€173 | -30.2% |
| Gross operating margin | 9900 | €68,972 | €206,609 | +€137,637 | +200% |
| Operating profit (loss) | 9901 | €66,781 | €204,182 | +€137,401 | +206% |
| Financial income | 75/76B | €920 | €920 | +€0 | 0.0% |
| Recurring financial income | 75 | €920 | €920 | +€0 | 0.0% |
| Financial charges | 65/66B | €1,991 | €2,054 | +€63 | +3.2% |
| Recurring financial charges | 65 | €1,991 | €2,054 | +€63 | +3.2% |
| Profit (loss) for the period before taxes | 9903 | €65,710 | €203,048 | +€137,337 | +209% |
| Income taxes | 67/77 | €23,870 | €65,806 | +€41,936 | +176% |
| Profit (loss) for the period | 9904 | €41,841 | €137,242 | +€95,401 | +228% |
| Profit (loss) for the period to be appropriated | 9905 | €41,841 | €137,242 | +€95,401 | +228% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.